| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 7467827
[patent_doc_number] => 20040053868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Protein kinase domain of the large subunit of herpes simplex type 2 ribonucleotide reductase (icp10pk) has anti-apoptotic activity'
[patent_app_type] => new
[patent_app_number] => 10/333607
[patent_app_country] => US
[patent_app_date] => 2003-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 18564
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20040053868.pdf
[firstpage_image] =>[orig_patent_app_number] => 10333607
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/333607 | Protein kinase domain of the large subunit of herpes simplex type 2 ribonucleotide reductase (icp 10pk) has anti-apoptotic activity | Jul 25, 2001 | Issued |
Array
(
[id] => 1164109
[patent_doc_number] => 06759394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-07-06
[patent_title] => 'Cancer gene therapy based on translational control of a suicide gene'
[patent_app_type] => B2
[patent_app_number] => 09/916017
[patent_app_country] => US
[patent_app_date] => 2001-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 11274
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/759/06759394.pdf
[firstpage_image] =>[orig_patent_app_number] => 09916017
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/916017 | Cancer gene therapy based on translational control of a suicide gene | Jul 25, 2001 | Issued |
Array
(
[id] => 6243100
[patent_doc_number] => 20020045592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Genes identified as required for proliferation in escherichia coli'
[patent_app_type] => new
[patent_app_number] => 09/912020
[patent_app_country] => US
[patent_app_date] => 2001-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 33231
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20020045592.pdf
[firstpage_image] =>[orig_patent_app_number] => 09912020
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/912020 | Genes identified as required for proliferation in escherichia coli | Jul 22, 2001 | Abandoned |
Array
(
[id] => 6774631
[patent_doc_number] => 20030017969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Methods and pharmaceutical compositions for healing wounds'
[patent_app_type] => new
[patent_app_number] => 10/169801
[patent_app_country] => US
[patent_app_date] => 2002-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 20049
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017969.pdf
[firstpage_image] =>[orig_patent_app_number] => 10169801
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/169801 | Methods and pharmaceutical compositions for healing wounds | Jul 22, 2001 | Issued |
| 09/787633 | INHIBITORS OF YCF24 AS ANTIMALARIALS | Jul 9, 2001 | Abandoned |
Array
(
[id] => 6064128
[patent_doc_number] => 20020032165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-14
[patent_title] => 'Microspheres and adjuvants for DNA vaccine delivery'
[patent_app_type] => new
[patent_app_number] => 09/901829
[patent_app_country] => US
[patent_app_date] => 2001-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11214
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20020032165.pdf
[firstpage_image] =>[orig_patent_app_number] => 09901829
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/901829 | Microspheres and adjuvants for DNA vaccine delivery | Jul 8, 2001 | Abandoned |
Array
(
[id] => 6274652
[patent_doc_number] => 20020106355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Novel regulatory sequences of the MCP-1 gene'
[patent_app_type] => new
[patent_app_number] => 09/899276
[patent_app_country] => US
[patent_app_date] => 2001-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8296
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20020106355.pdf
[firstpage_image] =>[orig_patent_app_number] => 09899276
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/899276 | Novel regulatory sequences of the MCP-1 gene | Jul 5, 2001 | Abandoned |
| 09/869659 | High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transciption regulatory site | Jun 28, 2001 | Abandoned |
Array
(
[id] => 6755807
[patent_doc_number] => 20030003584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Liposomal vector binding protein for hepatocyte DNA delivery'
[patent_app_type] => new
[patent_app_number] => 09/681938
[patent_app_country] => US
[patent_app_date] => 2001-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 97
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20030003584.pdf
[firstpage_image] =>[orig_patent_app_number] => 09681938
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/681938 | Liposomal vector binding protein for hepatocyte DNA delivery | Jun 27, 2001 | Abandoned |
Array
(
[id] => 6567899
[patent_doc_number] => 20020165178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Immunostimulatory nucleic acids for the treatment of anemia, thrombocytopenia, and neutropenia'
[patent_app_type] => new
[patent_app_number] => 09/895007
[patent_app_country] => US
[patent_app_date] => 2001-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19846
[patent_no_of_claims] => 137
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20020165178.pdf
[firstpage_image] =>[orig_patent_app_number] => 09895007
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/895007 | Immunostimulatory nucleic acids for the treatment of anemia, thrombocytopenia, and neutropenia | Jun 27, 2001 | Abandoned |
Array
(
[id] => 5829193
[patent_doc_number] => 20020068714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-06
[patent_title] => 'Tolerance and chronic hepatitis C virus'
[patent_app_type] => new
[patent_app_number] => 09/894845
[patent_app_country] => US
[patent_app_date] => 2001-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8228
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20020068714.pdf
[firstpage_image] =>[orig_patent_app_number] => 09894845
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/894845 | Tolerance and chronic hepatitis C virus | Jun 26, 2001 | Issued |
Array
(
[id] => 6636653
[patent_doc_number] => 20020086842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-04
[patent_title] => 'Method for transfecting cells using a magnetic field'
[patent_app_type] => new
[patent_app_number] => 09/895019
[patent_app_country] => US
[patent_app_date] => 2001-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 29548
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20020086842.pdf
[firstpage_image] =>[orig_patent_app_number] => 09895019
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/895019 | Method for transfecting cells using a magnetic field | Jun 25, 2001 | Abandoned |
Array
(
[id] => 6721316
[patent_doc_number] => 20030055006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/tie receptor function and their use'
[patent_app_type] => new
[patent_app_number] => 09/887527
[patent_app_country] => US
[patent_app_date] => 2001-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17130
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20030055006.pdf
[firstpage_image] =>[orig_patent_app_number] => 09887527
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/887527 | Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/tie receptor function and their use | Jun 24, 2001 | Abandoned |
Array
(
[id] => 6715453
[patent_doc_number] => 20030026801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Methods for enhancing antibody-induced cell lysis and treating cancer'
[patent_app_type] => new
[patent_app_number] => 09/888326
[patent_app_country] => US
[patent_app_date] => 2001-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 26167
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20030026801.pdf
[firstpage_image] =>[orig_patent_app_number] => 09888326
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/888326 | Methods for enhancing antibody-induced cell lysis and treating cancer | Jun 21, 2001 | Issued |
Array
(
[id] => 6016920
[patent_doc_number] => 20020103150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Control of metabolism with human 2-oxoglutarate carrier'
[patent_app_type] => new
[patent_app_number] => 09/888264
[patent_app_country] => US
[patent_app_date] => 2001-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16427
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20020103150.pdf
[firstpage_image] =>[orig_patent_app_number] => 09888264
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/888264 | Control of metabolism with human 2-oxoglutarate carrier | Jun 21, 2001 | Issued |
| 09/787559 | REGULATORY PROTEIN FROM HUMAN KERATINOCYTES | Jun 17, 2001 | Abandoned |
Array
(
[id] => 6510045
[patent_doc_number] => 20020025941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-28
[patent_title] => 'Combination product intended for carrying out a cytotoxic treatment, in particular an antitumour treatment, in a mammal'
[patent_app_type] => new
[patent_app_number] => 09/880038
[patent_app_country] => US
[patent_app_date] => 2001-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12650
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20020025941.pdf
[firstpage_image] =>[orig_patent_app_number] => 09880038
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/880038 | Combination product intended for carrying out a cytotoxic treatment, in particular an antitumour treatment, in a mammal | Jun 13, 2001 | Abandoned |
Array
(
[id] => 6278357
[patent_doc_number] => 20020107171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Regulation of the P21 gene and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/881635
[patent_app_country] => US
[patent_app_date] => 2001-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5462
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20020107171.pdf
[firstpage_image] =>[orig_patent_app_number] => 09881635
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/881635 | Regulation of the P21 gene and uses thereof | Jun 13, 2001 | Abandoned |
Array
(
[id] => 5969035
[patent_doc_number] => 20020091095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-11
[patent_title] => 'Modulation of Fas and FasL expression'
[patent_app_type] => new
[patent_app_number] => 09/879668
[patent_app_country] => US
[patent_app_date] => 2001-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7760
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20020091095.pdf
[firstpage_image] =>[orig_patent_app_number] => 09879668
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/879668 | Modulation of Fas and FasL expression | Jun 11, 2001 | Abandoned |
Array
(
[id] => 6594375
[patent_doc_number] => 20020042132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-11
[patent_title] => 'Mammalian gamete and embryo culture media supplement and method of using same'
[patent_app_type] => new
[patent_app_number] => 09/877395
[patent_app_country] => US
[patent_app_date] => 2001-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5929
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20020042132.pdf
[firstpage_image] =>[orig_patent_app_number] => 09877395
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/877395 | Mammalian gamete and embryo culture media and culture media supplements | Jun 7, 2001 | Issued |
